AJANTA PHARMA
Quarterly Results Analysis [Sep2024]
AJANTA PHARMA Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,187 Cr | ₹1,145 Cr | ₹1,054 Cr | ₹1,105 Cr | ₹1,028 Cr | ₹1,021 Cr | ₹882 Cr | ₹972 Cr |
Expenses | ₹875 Cr | ₹815 Cr | ₹776 Cr | ₹791 Cr | ₹738 Cr | ₹750 Cr | ₹732 Cr | ₹802 Cr |
Operating Income | ₹311 Cr | ₹330 Cr | ₹278 Cr | ₹314 Cr | ₹291 Cr | ₹271 Cr | ₹149 Cr | ₹170 Cr |
Other Income | ₹19 Cr | ₹26 Cr | ₹36 Cr | ₹14 Cr | ₹21 Cr | ₹32 Cr | ₹37 Cr | ₹35 Cr |
Interest | ₹6 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr |
Depreciation | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr |
Profit Before Tax | ₹290 Cr | ₹322 Cr | ₹278 Cr | ₹291 Cr | ₹276 Cr | ₹269 Cr | ₹152 Cr | ₹168 Cr |
Profit After Tax | ₹216 Cr | ₹246 Cr | ₹203 Cr | ₹210 Cr | ₹195 Cr | ₹208 Cr | ₹122 Cr | ₹135 Cr |
EPS | ₹17.27 | ₹19.61 | ₹16.04 | ₹16.62 | ₹15.46 | ₹16.47 | ₹9.68 | ₹10.46 |
Industry Peers & Returns | 1W | 1M | 1Y |
AJANTA PHARMA | -0.9% | -0.5% | 45% |
SUN PHARMACEUTICAL INDUSTRIES | -0% | 0.5% | 46.9% |
CIPLA | -2.1% | -6.9% | 19.3% |
DR REDDYS LABORATORIES | -0.6% | -3.3% | 7.4% |
ZYDUS LIFESCIENCES | -1.9% | 0.7% | 54.5% |
DIVIS LABORATORIES | -3% | 0.9% | 61.2% |
MANKIND PHARMA | 2.5% | 0.2% | 34.3% |
TORRENT PHARMACEUTICALS | -0.1% | 5.6% | 64.3% |
LUPIN | -0.7% | 1.6% | 73.6% |
AJANTA PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 3.64 % |
Y-o-Y | 15.38 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹1,187 Cr | 3.64 | |
Jun2024 | ₹1,145 Cr | 8.62 | |
Mar2024 | ₹1,054 Cr | -4.62 | |
Dec2023 | ₹1,105 Cr | 7.46 | |
Sep2023 | ₹1,028 Cr | 0.72 | |
Jun2023 | ₹1,021 Cr | 15.79 | |
Mar2023 | ₹882 Cr | -9.25 | |
Dec2022 | ₹972 Cr | - |
AJANTA PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -5.81 % |
Y-o-Y | 7.06 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹311 Cr | -5.81 | |
Jun2024 | ₹330 Cr | 18.69 | |
Mar2024 | ₹278 Cr | -11.38 | |
Dec2023 | ₹314 Cr | 8.05 | |
Sep2023 | ₹291 Cr | 7.13 | |
Jun2023 | ₹271 Cr | 81.64 | |
Mar2023 | ₹149 Cr | -11.90 | |
Dec2022 | ₹170 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -9.12 % |
Y-o-Y | -7.22 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 26.22% | -9.12 | |
Jun2024 | 28.85% | 9.28 | |
Mar2024 | 26.4% | -7.11 | |
Dec2023 | 28.42% | 0.57 | |
Sep2023 | 28.26% | 6.36 | |
Jun2023 | 26.57% | 56.85 | |
Mar2023 | 16.94% | -2.92 | |
Dec2022 | 17.45% | - |
AJANTA PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -11.92 % |
Y-o-Y | 10.84 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹216 Cr | -11.92 | |
Jun2024 | ₹246 Cr | 21.24 | |
Mar2024 | ₹203 Cr | -3.48 | |
Dec2023 | ₹210 Cr | 7.54 | |
Sep2023 | ₹195 Cr | -6.16 | |
Jun2023 | ₹208 Cr | 70.24 | |
Mar2023 | ₹122 Cr | -9.11 | |
Dec2022 | ₹135 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -15.04 % |
Y-o-Y | -3.95 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 18.24 % | -15.04 | |
Jun2024 | 21.47 % | 11.65 | |
Mar2024 | 19.23 % | 1.21 | |
Dec2023 | 19 % | 0.05 | |
Sep2023 | 18.99 % | -6.82 | |
Jun2023 | 20.38 % | 47.04 | |
Mar2023 | 13.86 % | 0.14 | |
Dec2022 | 13.84 % | - |
AJANTA PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -11.93 % |
Y-o-Y | 11.71 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹17.27 | -11.93 | |
Jun2024 | ₹19.61 | 22.26 | |
Mar2024 | ₹16.04 | -3.49 | |
Dec2023 | ₹16.62 | 7.50 | |
Sep2023 | ₹15.46 | -6.13 | |
Jun2023 | ₹16.47 | 70.14 | |
Mar2023 | ₹9.68 | -7.46 | |
Dec2022 | ₹10.46 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD